Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. A clinical study of (New Zealand black x New Zealand white)F1 mice
- PMID: 3530255
- DOI: 10.1002/art.1780290912
Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. A clinical study of (New Zealand black x New Zealand white)F1 mice
Abstract
A new method for measuring DNA antibody forming cells (DNA-AFC) using the enzyme-linked immunospot (ELISPOT) assay is described. This method uses enzyme-linked immunosorbent assay (ELISA) techniques applied to cells cultured on DNA-coated plates, which allows visual quantitation of spots representing imprints of specific antibodies from DNA-AFC. Specificity for DNA was confirmed by inhibition studies and lack of reactivity by anti-lysozyme hybridomas. Isotypes of IgG and IgM can be measured using the appropriate antisera in the assay. A study of 16 female (New Zealand black x New Zealand white)F1 ([NZB x NZW]F1) female mice showed significant correlation between age, rising blood urea nitrogen levels, and increasing proteinuria and increasing numbers of DNA-AFC. In contrast, the correlation between circulating antibodies to DNA (ELISA method) and clinical parameters of nephritis was not significant. Both the native DNA ELISPOT and the native DNA ELISA had similar significant linear correlations with age. This is the first report of use of the ELISPOT assay for measurement of DNA-AFC. The DNA-AFC measured by this method were specific and correlated with the presence of clinical nephritis in (NZB x NZW)F1 mice. This method should allow further study on the regulation of DNA-AFC in vitro and in vivo, and will be useful in the investigation of DNA-AFC and cellular mechanisms of autoimmunity.
Similar articles
-
Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.J Exp Med. 1992 Sep 1;176(3):761-79. doi: 10.1084/jem.176.3.761. J Exp Med. 1992. PMID: 1512540 Free PMC article.
-
Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.J Immunol. 1999 Apr 15;162(8):4406-16. J Immunol. 1999. PMID: 10201976
-
Properties of tRNA-specific antibodies from NZB/NZW mice.J Immunol. 1977 Mar;118(3):1016-24. J Immunol. 1977. PMID: 321680
-
Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.J Clin Invest. 1982 Sep;70(3):587-97. doi: 10.1172/jci110651. J Clin Invest. 1982. PMID: 6980900 Free PMC article.
-
Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.Immunol Cell Biol. 2011 Jan;89(1):90-9. doi: 10.1038/icb.2010.75. Epub 2010 Jun 15. Immunol Cell Biol. 2011. PMID: 20548325 Review.
Cited by
-
Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.J Clin Invest. 1990 Jan;85(1):238-47. doi: 10.1172/JCI114418. J Clin Invest. 1990. PMID: 1688569 Free PMC article.
-
Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease.J Clin Invest. 1990 Oct;86(4):1249-54. doi: 10.1172/JCI114831. J Clin Invest. 1990. PMID: 2212009 Free PMC article.
-
The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.J Exp Med. 1993 Jan 1;177(1):155-64. doi: 10.1084/jem.177.1.155. J Exp Med. 1993. PMID: 8418197 Free PMC article.
-
Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells.J Exp Med. 1991 Apr 1;173(4):881-7. doi: 10.1084/jem.173.4.881. J Exp Med. 1991. PMID: 2007856 Free PMC article.
-
Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.J Clin Invest. 1990 Sep;86(3):769-76. doi: 10.1172/JCI114773. J Clin Invest. 1990. PMID: 2144300 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources